Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor.
about
Cerivastatin: the low-dose HMG-COA reductase inhibitor.Pharmacotherapy of hypercholesterolaemia: statins in clinical practice.Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits.Statins inhibit blastocyst formation by preventing geranylgeranylation.Lovastatin fails to improve motor performance and survival in methyl-CpG-binding protein2-null miceTargeting tumor cell metabolism with statins.New prospects for lipid-lowering drugs.Reduced plasma high-density lipoprotein cholesterol in hyperthyroid mice coincides with decreased hepatic adenosine 5'-triphosphate-binding cassette transporter 1 expression.GTSE1: a novel TEAD4-E2F1 target gene involved in cell protrusions formation in triple-negative breast cancer cell models.Acute effect of cerivastatin on cardiac regional ischemia in a rat model mimicking off-pump coronary surgery.Biopharmaceutical profile of cerivastatin: a novel HMG-CoA reductase inhibitor.Vanadium(iv and v) complexes of pyrazolone based ligands: Synthesis, structural characterization and catalytic applications.Characterization of a novel cytochrome P450 from Amycolatopsis sp. CGMCC1149 for hydroxylation of lovastatin.
P2860
Q34074683-162BA7EB-2E85-46C4-B64A-2C921C91549FQ34182077-495EBE1F-36FB-4C03-BB87-0DDB102CE4FDQ35041057-FC14F667-957A-4FD7-8CEE-78C52ECFB899Q36843235-EEDC3A00-8D37-46D7-ADD6-D03B1C51627EQ37462636-60A685F4-6FFE-4346-B36A-B127F20CA150Q37981833-C5348241-3E3D-4CE0-ACA9-E89943D3C29DQ40408992-58F9BC50-F225-4111-8EC9-7533F4E6FA8EQ41468234-022268D4-4FAB-4CA8-B134-BB3319534B4FQ41991044-2E9DAF5B-3E41-4027-AC98-6A611E7E16F8Q46821380-F94EC5E4-0746-4ACB-8E7D-30B9BE8BED67Q51560703-3A5D6F42-3678-4263-80DB-56478CD0F2C0Q51739402-A67CCFBB-0805-4351-8CEC-1B5AB5EA45C0Q54288816-E0307C61-E306-46A7-8CA6-5140B3BBE56F
P2860
Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Cerivastatin: pharmacology of ...... e HMG-CoA reductase inhibitor.
@en
type
label
Cerivastatin: pharmacology of ...... e HMG-CoA reductase inhibitor.
@en
prefLabel
Cerivastatin: pharmacology of ...... e HMG-CoA reductase inhibitor.
@en
P2093
P1433
P1476
Cerivastatin: pharmacology of ...... e HMG-CoA reductase inhibitor.
@en
P2093
Angerbauer R
Bischoff E
Bischoff H
Faggiotto A
Petzinna D
Pfitzner J
P304
P356
10.1016/S0021-9150(97)00188-3
P577
1997-11-01T00:00:00Z